Cure Alzheimer's Fund Cure Alzheimer's Fund

Brain Entry and Exit Consortium: Does Subarachnoid Lymphatic-Like Membrane Failure Compromise Glymphatic Clearance in Alzheimer’s Disease?

2024

This proposal will test whether age-dependent atrophy and loss of barrier function of the recently discovered meningeal membrane named subarachnoid lymphatic-like membrane (SLYM) contributes to recirculation of cerebrospinal fluid and amyloid beta accumulation. 

Brain Entry and Exit Maiken Nedergaard Studies of Alternative Neurodegenerative Pathways Translational

Funding to Date

$287,500

Focus

Studies of Alternative Neurodegenerative Pathways, Translational

Researchers

Maiken Nedergaard, M.D., D.M.Sc.

Related Content:


Evaluating the Contribution of TDP-43 Dysfunction and Cryptic Mis-Splicing to Alzheimer’s Disease Pathogenesis Leonard Petrucelli 2024-10-31 Role of Psychosocial Stress in Alzheimer’s Disease Filip Swirski 2024-10-31 Pre-Clinical Testing of CDK4/6 Inhibitors as a Therapeutic Strategy in Alzheimer’s Disease Using Alzheimer’s Disease Tauopathy Mouse Model Peter Sicinski 2024-09-24 Dysregulation of Signaling on Post Synaptic Density Scaffolds in Alzheimer’s Disease Alexandra C. Newton 2024-07-29 Novel Artificial Intelligence (AI) Decodes Aging Neurons Andrew J. Holbrook Theodore Zwang 2024-07-23 2-Deoxyglucose and Its Analogs as Novel Therapeutics to Build Resilience to Alzheimer’s Disease Rajiv R. Ratan Theodore J. Lampidis 2024-07-23 The Role of Calcium Homeostasis in Axonal Spheroid Formation in Alzheimer’s Disease Jaime Grutzendler 2024-06-13 Brain Entry and Exit Consortium: Neuroinflammation at the Choroid Plexus in Alzheimer’s Disease Maria Lehtinen 2024-05-02